Journal
NATURAL PRODUCTS AND BIOPROSPECTING
Volume 8, Issue 4, Pages 265-278Publisher
SPRINGER SINGAPORE PTE LTD
DOI: 10.1007/s13659-018-0179-5
Keywords
Rhizoma Paridis; Paris polyphylla; Alternative resources; Steroidal saponins; Bioactivities
Categories
Funding
- National Natural Science Foundation of China [31570363, 31770391, 31600283]
- Natural Science Foundation of Yunnan Province [2015FA031, 2017FB128]
- Science and Technology Research Program of Kunming Institute of Botany, CAS [KIB2016001]
- Guiding Program of Interdisciplinary Studies from Kunming Institute of Botany, CAS [KIB2017004]
- Foundation of State Key Laboratory of Phytochemistry and Plant Resources in West China [P2017-ZZ04]
- Kunming Institute of Botany, Chinese Academy of Sciences
Ask authors/readers for more resources
Rhizoma Paridis (RP, ), a traditional Chinese medicine, is the rhizoma of Paris polyphylla var. yunnanensis (PPY) or P. polyphylla var. chinensis which are widely used as important raw materials for several Chinese patent drugs. However, the wild resources of these herbs have become less and less due to their slow-growing characteristics and previously excessive excavation. This review covers untiring investigations on alternative resources of RP by our research group over the past decades, including non-medicinal parts of PPY as well as other plants of Liliaceae and Liliflorae families. The arial parts of PPY and the whole plants of Trillium kamtschaticum might be alternative resources for RP based on the fact that they shared the same or similar saponins and bioactivities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available